(162 days)
Not Found
No
The summary describes standard signal processing and data collection from sensors, without mentioning any AI/ML techniques for analysis or interpretation.
No
The device is described as a "diagnostic aid for the detection of sleep related breathing disorders" and is used to generate indices and identify sleep stages. It is explicitly stated that "PSTAGES and SBP are not intended to be used as the sole or primary basis for diagnosing any sleep related breathing disorder, prescribing treatment, or determining whether additional diagnostic assessment is warranted." This indicates its purpose is diagnostic, not therapeutic.
Yes
The "Intended Use / Indications for Use" section explicitly states, "The WP200U is a diagnostic aid for the detection of sleep related breathing disorders, sleep staging (Rapid Eye Movement (REM) Sleep, Light Sleep, Deep Sleep and Wake), snoring level and body position." The "Device Description" section also refers to it as a "diagnostic aid."
No
The device description explicitly lists multiple hardware components including a probe, actigraph, sensor, electronics, and power supply, in addition to the software.
Based on the provided information, the Watch-PAT200U (WP200U) device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Watch-PAT200U Function: The Watch-PAT200U is a non-invasive device that measures physiological signals directly from the patient's body (wrist and finger) using technologies like Peripheral Arterial Tonometry (PAT), pulse oximetry, and actigraphy. It does not analyze samples taken from the body.
- Intended Use: The intended use clearly states it's a "non-invasive home care device" and a "diagnostic aid for the detection of sleep related breathing disorders." This aligns with a device that monitors physiological parameters, not one that analyzes biological samples.
Therefore, the Watch-PAT200U falls under the category of a medical device that performs physiological measurements and analysis, but it is not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Watch-PAT200U (WP200U) device is a non-invasive home care device for use with patients suspected to have sleep related breathing disorders. The WP200U is a diagnostic aid for the detection of sleep related breathing disorders, sleep staging (Rapid Eye Movement (REM) Sleep, Light Sleep, Deep Sleep and Wake), snoring level and body position. The WP200U generates a peripheral arterial tonometry ("PAT") Respiratory Disturbance Index ("PRDI"), Apnea-Hypopnea index ("PAHI"), PAT sleep staging identification (PSTAGES) and optional snoring level and body position discrete states from an external integrated snoring and body position (SBP) sensor. The WP200U's PSTAGES and SBP provide supplemental information to its PRDI/PAHI. The WP200U's PSTAGES and SBP are not intended to be used as the sole or primary basis for diagnosing any sleep related breathing disorder, prescribing treatment, or determining whether additional diagnostic assessment is warranted.
Product codes (comma separated list FDA assigned to the subject device)
MNR
Device Description
The Watch-PAT200U System (WP200U) is a non-invasive home care device for use with patients suspected to have sleep related breathing disorders. The WP200U is a diagnostic aid for the detection of sleep related breathing disorders [Respiratory disturbance index (RDI), apnea - hypopnea index (AHI)] and sleep staging (Rapid Eye Movement (REM), Light Sleep, Deep Sleep and Wake) based on Peripheral Arterial Tonometry (PAT), a non-invasive technology. According to the physician discretion, the WP200U may be connected to an external integrated snoring and body position (SBP) sensor.
The WP200U device consists of the following: (1) a unified PAT and pulse oximeter probe which is used to detect the PAT signal and to measure blood oxygen saturation; (2) an embedded actigraph, which is used to determine periods of sleep based on the motion of the wrist; (3) external integrated snoring and body position sensor - SBP (Optional); (4) electronics, which include a controller that records the signals provided by the PAT finger probe, oximeter, actigraph and SBP; (5) the device software; and (6) a power supply.
The Watch-PAT200U is identical to the already cleared Watch-PAT200S-3 except for Itamar Medical pulse oximetry which replaces the existing Nonin pulse oximeter.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Non-invasive home care device
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
The study was conducted in accordance to ISO 14155, following the pulse oximetry guidelines of ISO 80601-2 applicable sections, and Pulse Oximeters - Premarket Notifications Submissions [510(k)s] Guidance For Industry and Food and Drug Administration Staff (issued: March 4, 2013).
The study was performed in CLINIMARK Laboratories and included eleven healthy adult volunteer subjects.
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance Testing
A series of safety and performance testing were performed to demonstrate that the WP200U does not raise any new issues of safety and efficacy. These tests include:
- Electrical safety and Electromagnetic compatibility testing per IEC 60601-1: 1988 . + A1: 1991 + A2: 1995; EN 60601-1:1990+A1:1993+A2:1995+A13:1996 and IEC 60601-1:2005 + CORR.1 (2006) + CORR.2 (2007) / EN60601-1:2006 and IEC 60601-1-2:2007 CISPR 11:2009 A1:2010 - Part 1-2 and 60601-1-11:2010
- Software verification and validation .
- Bench testing to show the addition of LEDs did not affect PAT signal . measurement
All these tests demonstrate that the WP200U is substantially equivalent to its predicate without raising any new issues of safety or effectiveness.
Clinical Data
The accuracy of the pulse oximeter was assessed in a clinical study.
The purpose of the study was to evaluate the SpO2 accuracy and performance of the Itamar Medical Pulse Oximetry system (WP200U) during non-motion conditions over the range of 70-100% SaO2 to arterial blood samples assessed by CO-Oximetry for SpO2 validation.
The results of the study provide supporting evidence that the SpO2 accuracy performance of the Itamar Medical WP200U pass an ARMs specification of ≤3 (Ams 2.1) under steady state / nonmotion conditions for the range 70-100%.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
ARMs specification of ≤3 (Ams 2.1) for SpO2 accuracy
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 868.2375 Breathing frequency monitor.
(a)
Identification. A breathing (ventilatory) frequency monitor is a device intended to measure or monitor a patient's respiratory rate. The device may provide an audible or visible alarm when the respiratory rate, averaged over time, is outside operator settable alarm limits. This device does not include the apnea monitor classified in § 868.2377.(b)
Classification. Class II (performance standards).
0
510(K) SUMMARY
510(K) Number K | 33859
| 5.1 | : Applicant's Name: | Itamar Medical Itd.
9 Halamish st.
Caesarea 38900, Israel
Tel: +972 4 617 7000
Fax: +972 4 627 5598 |
|-----|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 5.2 | Contact Person: | Jonathan Kahn, Esq.
Hogan Lovells US LLP
Columbia Square
555 Thirteenth Street, NW
Washington, DC 20004-1109
Tel: (202)637-5794
Fax: (202)637-5910 |
Email: jonathan.kahan@hoganlovells.com
- Date Prepared: December 19, 2013 5.3
5.4 Trade Name: Watch-PAT 200U ("WP200U")
5.5 Common or Usual Name: Ventilatory Effort Recorder
ક.દ Classification Name: Breathing Frequency Monitor
5.7 Medical Specialty: Anesthesiology
5.8 Product Code: Ventilatory Effort Recorder, MNR
5.9 Device Class: Class II
Regulation Number: 868.2375 5.10
5.11 Panel: Anesthesiology
5.12 Predicate Devices: ·
.
Watch-PAT200S-3 ("WP200S-3") (Itamar Ltd), cleared under K102567; product . code MNR (ventilatory effort recorder)
. 5.13 Intended Use / Indication for Use:
The Watch-PAT200U (WP200U) device is a non-invasive home care device for use with patients suspected to have sleep related breathing disorders. The WP200U is a diagnostic aid for the detection of sleep related breathing disorders, sleep staging (Rapid Eye Movement (REM) Sleep, Light Sleep, Deep Sleep and Wake), snoring level and body position. The WP200U generates a peripheral arterial tonometry ("PAT") Respiratory Disturbance Index ("PRDI"), Apnea-Hypopnea index ("PAHI"), PAT sleep staging identification (PSTAGES) and optional snoring level and body position discrete states from an external integrated snoring and body position (SBP) sensor. The WP200U's PSTAGES and SBP provide supplemental information to its PRDI/PAHI. The WP200U's
5-3
1
PSTAGES and SBP are not intended to be used as the sole or primary basis for diagnosing any sleep related breathing disorder, prescribing treatment, or determining whether additional diagnostic assessment is warranted.
Device Description: 5.14
The Watch-PAT200U System (WP200U) is a non-invasive home care device for use with patients suspected to have sleep related breathing disorders. The WP200U is a diagnostic aid for the detection of sleep related breathing disorders [Respiratory disturbance index (RDI), apnea - hypopnea index (AHI)] and sleep staging (Rapid Eye Movement (REM), Light Sleep, Deep Sleep and Wake) based on Peripheral Arterial Tonometry (PAT), a non-invasive technology. According to the physician discretion, the WP200U may be connected to an external integrated snoring and body position (SBP) sensor.
The WP200U device consists of the following: (1) a unified PAT and pulse oximeter probe which is used to detect the PAT signal and to measure blood oxygen saturation; (2) an embedded actigraph, which is used to determine periods of sleep based on the motion of the wrist; (3) external integrated snoring and body position sensor - SBP (Optional); (4) electronics, which include a controller that records the signals provided by the PAT finger probe, oximeter, actigraph and SBP; (5) the device software; and (6) a power supply.
The Watch-PAT200U is identical to the already cleared Watch-PAT200S-3 except for Itamar Medical pulse oximetry which replaces the existing Nonin pulse oximeter.
5.15 Substantial Equivalence:
- Intended Use
The intended use of the Watch-PAT200U is identical to the intended use of its predicate, the Watch-PAT200S-3 ("WP200S-3") (Itamar Ltd). The replacement of the Nonin pulse oximetry with Itamar Medical pulse oximetry does not alter the intended diagnostic use of the WP200U.
Comparison of Technological Characteristics
The WP200U, like its predicate the WP200S-3, is a ventilatory effort recorder that utilizes PAT technology.
The PAT probe was modified to include an oximeter feature by adding LED package to the probe including R and IR LEDs. Itamar's Pulse Oximeter, like the predicate Nonin pulse oximetry pulse oximeter, determines the arterial oxygen saturation from two wavelengths absorption spectrophotometry. The integration into the PAT sensor does.not raise any new types of safety and effectiveness questions as oxygen content is being measured the same way.
The WP200U's zzzPAT software was modified, as compared to the WP200S-3 predicate software, to include a new algorithm to calculate oxygen saturation. This new algorithm was incorporated into the WP200U offline software (zzzPAT) because the predicate Nonin pulse oximetry which computed this data in its hardware is no longer part of the system. As similar data is being analyzed to produce the same output (oxygen saturation), this change does not raise new types of safety and efficacy questions.
2
Performance Testing
A series of safety and performance testing were performed to demonstrate that the WP200U does not raise any new issues of safety and efficacy. These tests include:
- Electrical safety and Electromagnetic compatibility testing per IEC 60601-1: 1988 . + A1: 1991 + A2: 1995; EN 60601-1:1990+A1:1993+A2:1995+A13:1996 and IEC 60601-1:2005 + CORR.1 (2006) + CORR.2 (2007) / EN60601-1:2006 and IEC 60601-1-2:2007 CISPR 11:2009 A1:2010 - Part 1-2 and 60601-1-11:2010
- Software verification and validation .
- Bench testing to show the addition of LEDs did not affect PAT signal . measurement
All these tests demonstrate that the WP200U is substantially equivalent to its predicate without raising any new issues of safety or effectiveness.
Clinical Data
The accuracy of the pulse oximeter was assessed in a clinical study.
The purpose of the study was to evaluate the SpO2 accuracy and performance of the Itamar Medical Pulse Oximetry system (WP200U) during non-motion conditions over the range of 70-100% SaO2 to arterial blood samples assessed by CO-Oximetry for SpO2 validation.
The study was conducted in accordance to ISO 14155, following the pulse oximetry guidelines of ISO 80601-2 applicable sections, and Pulse Oximeters - Premarket Notifications Submissions [510(k)s] Guidance For Industry and Food and Drug Administration Staff (issued: March 4, 2013).
The study was performed in CLINIMARK Laboratories and included eleven healthy adult volunteer subjects.
The results of the study provide supporting evidence that the SpO2 accuracy performance of the Itamar Medical WP200U pass an ARMs specification of ≤3 (Ams 2.1) under steady state / nonmotion conditions for the range 70-100%.
Summarv
Based on the performance testing results, including the electrical and electromagnetic testing, clinical study, software verification and validation process and bench tests, Itamar Ltd. believes that the WP200U System is substantially equivalent to its predicate.
A clinical study was conducted to validate the WP200U SpO2 accuracy vs. Reference CO-Oximetry.
5-5
3
Image /page/3/Picture/0 description: The image is a black and white logo for the Department of Health & Human Services - USA. The logo consists of a stylized abstract symbol resembling a bird or a person reaching out, composed of three curved lines. The symbol is enclosed within a circle, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the circumference of the circle.
DEPARTMENT OF HEALTII & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
May 30, 2014
Itamar Medical LTD C/O Jonathan Kahan Esq. RA Consultant Hogan Lovells US LLP Columbia Square 555 Thirtcenth Street, NW Washington DC, 20004
Re: K133859
Trade/Device Name: Watch-PAT200U (WP200U) Regulation Number: 21 CFR 868.2375 Regulation Name: Ventilatory Effort Recorder Class: Il Product Code: MNR Dated: May 2, 2014 Received: May 2, 2014
Dear Mr. Kahan:
We have reviewed your Section 510(k) premarket notification of intent to market the device indication We have reviewed your Section 910(x) prematics is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to commerce prior to May 28, 1970, the charment and of the Federal Food. Drug, devices that have been reclassified in accordance while approval application (PMA).
and Cosmelic Act (Act) that do not require approval of a previsions of the Act and Cosment Act (Act) that do not require upprovince the general controls provisions of the Act. You may, therefore, market the device, subject to the Lenor of increasing for annual registration, listing of I he general controls provisions of the line and prohibitions against misbranding and devices, good manufacturing practice. (aboring) and information related to contract liability. adulteration. Please note: CDRT does not evaluate information be truthful and not misleading.
If your device is classified (scc above) into either class II (Special Controls) or class III (PMA). it may be subject to additional controls. Existing major regulations affecting your device can be may be subject to additional Controls. Existing mayor vis 800 to 898. In addition, FDA may found in the Code of Technical Progulations, This device in the Federal Register,
4
Page 2 – Mr. Kahan
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801). please contact the Division of Small Manufacturers, International and Consumer Assistance at its tollfree number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to promarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/dcfault.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the rou may outment. Benefurers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its internet address http://www.fda.gov/MedicalDevices/Resources/or You/Industrv/default.htm.
Sincerely vours.
http://www.fda.gov/MedicalDevices/ResourcesforYourIndustry/default.htm.
新
Tejashri Purohit Sheth, M.D.
Tejashri Purohit Sheth M. D. Clinical Deputy Director
DAGRID/ODE/CDRH FOR
i
Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
INDICATIONS FOR USE
510(k) Number (if known): K133859
Device Name: Watch-PAT200U (WP200U)
Indications for Use:
The Watch-PAT200U (WP200U) device is a non-invasive home care device for use with patients suspected to have sleep related breathing disorders. The WP200U is a diagnostic aid for the detection of sleep related breathing disorders, sleep staging (Rapid Eye Movement (REM) Sleep, Light Sleep, Deep Sleep and Wake), snoring level and body position. The WP200U generates a peripheral arterial tonometry ("PAT") Respiratory Disturbance Index ("PRDI"), Apnea-Hypopnea index ("PAHI"), PAT sleep staging identification (PSTAGES) and optional snoring level and body position discrete states from an external integrated snoring and body position (SBP) sensor. The WP200U's PSTAGES and SBP provide supplemental information to its PRDI/PAHI. The WP200U's PSTAGES and SBP are not Intended to be used as the sole or primary basis for diagnosing any sleep related breathing disorder, prescribing treatment, or determining whether additional diagnostic assessment is warranted.
Prescription Use V V (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use _ (21 CFR 801 Subpart C)
(Please DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page 1 of 1
Image /page/5/Picture/12 description: The image shows a collection of black dots scattered across a white background. The dots are arranged in clusters, forming shapes that resemble a map or a constellation. The density of the dots varies across the image, with some areas having a higher concentration than others. The overall impression is one of randomness and complexity.
Anya C. Harry -S 2014.05.29 22:10:39 -04'00'
4-2